A randomized, open-label, single-dosing, 2x2 crossover study to compare the safety and pharmacokinetics of UI014 tablet with UIC201606 under fed conditions in healthy male volunteers.
Latest Information Update: 24 Sep 2019
At a glance
- Drugs UI 014 (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Korea United Pharm Inc
Most Recent Events
- 24 Sep 2019 New trial record